Senphonix
Senphonix is a MedTech startup dedicated to transforming patient monitoring through intelligent, automated, and continuous vital signs tracking. Their mission is to close the gap between data and action in healthcare, enabling precision, clarity, and compassion for patients, clinicians, and healthcare systems. By leveraging breakthrough wearable technology and secure, cloud-based software, Senphonix aims to reduce clinician burden, improve patient outcomes, and drive efficiency across the continuum of care. The company is headquartered in Minnesota and Arizona, and collaborates with leading academic and healthcare partners to bring next-generation solutions to market.
Senphonix
59 Fourth Street West, Suite 21D, St. Paul, MN 55102
What We Do
SleeveSense™ is an adhesive-free, mesh vitals sleeve that wirelessly charges and captures continuous, clinical-grade biosignals data. It integrates with Senphonix's secure cloud via encrypted Bluetooth® and/or LoRa® protocols, enabling seamless EHR integration, real-time alerts, and long-term monitoring. Designed for comfort and durability, it can be worn for extended periods without removal, supporting heart rate, respiration, temperature, movement, and more. SleeveSense™ is expected to be available after FDA evaluation.
Senphonix provides intelligent, scalable solutions for automated, continuous patient monitoring, delivering real-time insights, reducing clinician burden, and driving efficiency across healthcare settings. Their platform integrates with major EHRs and supports real-time alerts and long-term insights.
Senphonix offers a secure, HIPAA-compliant platform built on Microsoft Azure, enabling seamless integration with electronic health records (EHRs), real-time alerts, and long-term data insights for healthcare providers.
Senphonix provides consulting services to ensure their technology is practical, scalable, and impactful in real-world clinical settings, including workflow integration, provider adoption, and healthcare system efficiency.
Application Area
Show More (2)Battlefield Resuscitation
Psychological and Cognitive Health and Performance
Regenerative Medicine
Key People
Co-Founder and Co-CEO
Co-Founder and Co-CEO
Clinical Affairs Consultant
Healthcare Policy Consultant
Med Device Technology Consultant
News & Updates
Senphonix holds an exclusive, worldwide license from the University of Arizona to the core intellectual property utilized in its SleeveSense product.
Market research conducted by MarketWise Advising in April 2025 validated a 98% market need/solution match for SleeveSense, with 95% confidence (n=402; +/- 5% error rate).
Senphonix's leadership team has deep experience in bringing breakthrough healthcare technologies to market and scaling them successfully.
Academic paper by Dr. Gutruf and colleagues on biosymbiotic platforms for chronic monitoring.
Academic paper discussing the challenges and opportunities in wearable biosignal monitoring.
Academic paper on electromagnetic design for wearable biosymbiotic devices.